Roughly 1 in 50 promising cancer drug candidates makes it to market. What’s holding the other 49 back?
Nicole Fawcett is the manager of cancer communication for the University of Michigan Comprehensive Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined the University of Michigan Health System in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
The finding suggests a potential therapy to slow the disease in patients or a possible preventive strategy for women at high risk for ovarian cancer.
A new study finds doctors are appropriately using a genetic test to measure breast cancer recurrence risk and to make tailored treatment recommendations.
Part of the national Cancer Moonshot, a new data repository of cancer patients’ analyzed blood samples aims to stimulate translational research across industry and academia.
A new study calls attention to the need for better partnerships between primary care physicians and oncologists.
A new national initiative will change the face of clinical trials for pancreatic cancer through collaboration among researchers, clinicians and pharma.